GENEVA, 26 OCTOBER - Following the review of guidance
on smallpox vaccination I announced last week, WHO has consulted with
our advisory committee and has updated the official guidance.
The conclusion of the review states that:
"Existing vaccines have proven efficacy but also have
a high incidence of adverse side-effects. The risk of adverse events is
sufficiently high that mass vaccination is not warranted if there is no
or little real risk of exposure. Individual countries that have reason
to believe that their people face an increased risk of smallpox because
of deliberate use of the virus are considering options for increasing
their access to vaccines. The vaccines would be given to people who are
at risk of exposure to smallpox, including health and civil workers, and
would be used in a search and containment exercise should an outbreak
occur."
In summary, the guidance is that vaccination of
entire populations is not recommended. The reason for not recommending
such mass vaccination is that there is a risk of severe reactions to the
vaccine, including death, and the fact that vaccination can prevent
smallpox even after exposure to the virus.
Up to now the guidance has also stated that only
those with suspected exposure to smallpox or a related virus should be
vaccinated. That has not changed.
What has changed is the increasing attention being given to the
extent and quality of existing vaccine stocks, and to the possible need
both to stimulate vaccine production and increase stocks of vaccine for
use in the event of an outbreak.
WHO confirms that the best method of stopping a
smallpox outbreak, should it occur, remains the same search and
containment. That means identifying persons with smallpox, identifying
those people who have been in contact with them, and vaccinating them.
People who have been vaccinated in the past are
unlikely to develop the most serious effects of smallpox.
This advice and background information on smallpox is
now being made available to governments through the WHO website. Along
with this advice we are providing Frequently asked Questions and Answers
about smallpox and a smallpox Fact Sheet with an electronic slide set of
training materials on smallpox. Other information that will be provided
to Health Ministers on request includes a list of vaccine manufacturers
that have the potential to produce smallpox vaccine and the names of
laboratories that can diagnose smallpox. WHO has also re-established a
team of technical experts in smallpox who are available to assist
countries in the investigation and response to outbreaks.
Finally, I want to emphasize that should an outbreak
of smallpox be detected in any country, this should be considered an
international emergency. WHO will help countries to pool available
resources so as to contain the disease as rapidly and effectively as
possible.